Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and novel digital source.
Nanox’s vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically-driven approach. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; Nanox.AI – an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages and stores data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE, a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc. that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance its better health outcomes worldwide.
Our Leadership
CEO & ACTING CHAIRMAN OF THE BOARD
Erez Meltzer, the Chief Executive Officer and the Acting Chairman of the Board. Prior to this role, he held the position of Chairman of the Board at Hadassah Medical Center in Israel for a duration of six years. Throughout his career, he has also assumed leadership roles in several prominent global companies, including Gadot Chemicals & Shipping Group, Africa Israel, Netafim, and Creo Scitex.
Ms. Kainan has served as a member of our board of directors since February 2021. Ms. Kainan established the forum for owners, chairpersons, and CEOs, she also serves as chairperson of the CFO Forum. Kainan serves as member in the Israeli Prime Minister’s Office committees, Board of Trustees of Bar Ilan University, and other NGOs. She served as a director of companies traded on the TASE. Kainan, co-authored the book “Israel – Island of Success”. Kainan holds an MBA from Tel Aviv University.
Michael Jackman served as the CEO of the Leidos (LDOS) health group from 2020 to 2024. Prior to that, Mr. Jackman was the CEO of Mach7 Technologies, from 2017 to 2019, a company which focused on modernizing enterprise imaging. In addition, Mr. Jackman was a senior executive at GE Healthcare from 2011 to 2017, serving as the Americas Region CEO for Healthcare Digital (HCIT) and as the General Manager for Enterprise Imaging and care delivery solutions. Prior to 2011, Mr. Jackman held leadership roles for Carestream Health (President HCIT), iSOFT Health Group (EVP Operations), and Eastman Kodak (CTO of Healthcare division) and lastly at IBM, where he started his career in hardware and software and held several leadership positions. Mr. Jackman holds a BSEE in Electrical Engineering from University of Rhode Island, and an MBA in Business Administration from Nova University.
Mr. Suesskind served as the CFO of Teva Pharmaceuticals for 31 years, and as a director at numerous companies in the medical field. He is currently a director of NANO-X Imaging limited, IMED Infinity Medical, NEXTAR Chemopharma Solutions Ltd, SaNOtize R&D Corp, and The Jerusalem Foundation.
Erez Alroy for almost 20 years held various positions in the Shahal group, including 15 years as chief executive officer of SHL Telemedicine (SIX: SHLTN). Currently Mr. Alroy is a private investor and holds several board positions, including SHL Telemedicine Ltd. and Merhavia Holdings and Investments Ltd. (TASE), an investment firm that invests mainly in life science and healthcare companies. Mr. Alroy holds an MBA degree from the Hebrew University of Jerusalem.
Nehama Ronen, former Director General of the Israeli Ministry of Environmental Protection (1996-1999) and member of the Israeli Knesset (2001-2003), is currently the Chairperson of Maman Cargo Terminals & Handling Ltd. She has been actively involved in environmental and logistical leadership roles since then, including her executive chairmanship at ELA Recycling Corporations from 2005-2019.Additionally, Ms. Ronen has contributed to various boards, such as Tamar Petroleum Ltd., Dan Public Transportation, and Trendlines Group. With a strong commitment to environmental causes, she served on the board of Oil Refineries Ltd. (2008-2011) and Bank Hapoalim (2010-2015) , holds a B.A. in Education and History from Tel Aviv University and Beit Berl College, as well as an M.A. in Public Management from Haifa University. Ms. Ronen also graduated a Senior executive Program at the London Business School.
Dr. Kicska is an assistant professor in the thoracic section of the Department of Radiology at Harborview Medical Center in Seattle, Washington, where he also conducts research on digital chest tomosynthesis.
Department of Imaging. The Whittington Hospital London
Thomas (Tom) Dekle, Jr.Client Executive, IBM
General & Trauma Surgeon
Dr. Pickhardt is a Professor of Radiology at the University of Wisconsin Medical School, with more than 25 years of experience in the diagnostic radiology field.
Professor and Chairman of the Department of Medical Imaging at the University of Arizona.
Dr. Tanenbaum is an active consultant in the imaging space. He is a long-term collaborator with the medical imaging industry and continues to chair advisory boards for imaging OEMs, pharma, and AI concerns. He has interests in developing applications of AI and machine learning, contrast agents, MR, CT and advanced rendering.
Dr. Tanenbaum served as Vice President, Chief Technology Officer and Director of Advanced Imaging at Radnet Inc from 2015 -2024.
CEO & ACTING CHAIRMAN OF THE BOARD
Erez Meltzer, the Chief Executive Officer and the Acting Chairman of the Board. Prior to this role, he held the position of Chairman of the Board at Hadassah Medical Center in Israel for a duration of six years. Throughout his career, he has also assumed leadership roles in several prominent global companies, including Gadot Chemicals & Shipping Group, Africa Israel, Netafim, and Creo Scitex.
General Manager of Source & Services Division & Head of Nanox USA
Mr. Dara has held senior executive roles in multinational companies, serving in his last position as President of MyCharge, and prior to that as VP of Business Development at Powermat, and VP and interim CEO at Wellsense.
Chief financial officer
Mr. Daniel has over 25 years of financial and business management experience. Ran was in charge of the financial and accounting functions in several companies, bringing extensive experience working as a CFO in both rapidly growing companies and publicly traded companies.
EVP & Chief Marketing Officer
Ms. Aharon Cohen has over a decade of experience at global corporations, serving in her last position as CEO at Tempo-Heineken Cyprus, and prior to that as Division Manager and Marketing Manager at Tempo-Heineken Israel.
General Manager of ARC Division
Mr. Koren is a seasoned technological leader who served as General Manager and VP R&D at ReWalk Robotics, GM of RuggedCom, and VP R&D of Alvarion, leading the development of their WiMax mobile solution.
Chief Medical Officer
Dr. Wimpfheimer previously held the position of Chief Medical Officer and Head of Product Strategy at Zebra Medical Vision, until its acquisition by Nanox. She is the co-founder of Remote Radiology International, with over 20 years of experience in the radiology field. She received her medical degree from Albert Einstein College of Medicine and did her diagnostic radiology residency at New York Presbyterian Hospital in New York.
CHIEF LEGAL OFFICER (GC)
Prior to joining Nanox, Ms. Gofman Feler served as General Counsel at CollPlant Biotechnologies Ltd., a publicly traded biotechnology company. Marina holds an LL.B in Laws and a B.A in Economics from Tel Aviv University.
COS & VP CORPORATE RESOURCES
Prior to joining Nanox, Ms. Attias held the position of Chief of Staff at the Hadassah Medical Center for over 14 years. She holds a BA in Liberal Arts and Sciences from the Open University of Israel, and company Director and Corporate Officer training at the Reichman University.
VP US Region
Head of Tomosynthesis, ARC Division
VP R&D Marketplace
VP R&D & COO, AI Division
Chief Executive Officer of USARAD Holdings Inc.
President& CMO, USARAD Holdings Inc.
Clinical Strategy, ARC Division
Chairman of Nanox Korea
Significant Unmet Need
meaningful access to medical imaging
We aim to build a global infrastructure for medical imaging, combining powerful technologies: our digital MEMS source, AI solutions and teleradiology solutions for an end-to-end imaging solution
The Future is Now
Client portal